"Biomarkers in Thoracic Oncology" is an interactive, gamified activity designed to enhance knowledge of current and emerging biomarkers in thoracic oncology. Through a quiz format featuring multiple-choice questions, participants receive immediate feedback and track progress on a leaderboard, fostering engaging learning on biomarker applications in clinical decision-making for thoracic cancers.
Course Accreditations
0.25 AMA PRA Category 1 Credit™ The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 1.00 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission. 0.25 Nursing Contact Hours Provider approved by the California Board of Registered Nursing, Provider # CEP17035, for 1.00 Contact Hours. 0.25 ABIM MOC II Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Course Summary
| Events Starts | Events Ends |
|---|---|
| 3/12/2025 | 3/12/2025 |
- Medical Oncologists
- Surgeons
- Radiation Oncologists
- Pathologists
- Oncology Fellows
- Oncology Nurses
- Nurse Practitioners
- Physician Assistants
- Pharmacists
Target Audience
- Identify key current and emerging biomarkers used in the diagnosis and treatment of thoracic cancers.
- Evaluate the clinical significance of specific biomarkers in guiding therapeutic decisions for patients with thoracic malignancies.
- Apply biomarker knowledge to enhance personalized treatment strategies and improve patient outcomes in thoracic oncology.
Learning Objectives
Upon successful completion of this educational activity, participants will be able to: